Mark Kelly

Licensing Manager

Profile

Mark was previously on the Senior Management Team at Xenova Research Plc, Cambridge where he was Head of Assay Development, aiding in developing a number of novel protein and viral vaccines against a range of infectious diseases and cancer targets. For over 10 years he was closely involved in the development of all the biopharmaceutical projects run by the company and in technology transfer projects with other leading global pharmaceutical companies.

Mark has an Hons. degree in Biochemistry and a Masters degree in Medical Molecular Biology. 

Contact details